Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 670 results for "warner chilcott"


(Edgar Glimpses Via Acquire Media NewsEdge) The following discussion of our financial condition and the results of operations should be read in conjunction with the "Consolidated Financial Statements" and notes thereto included elsewhere in this ... TMC Net, 2 weeks ago

8-K/A - Warner Chilcott Ltd (0001620602) (Filer)

Document Format Files Seq Description Document Type Size 1 FORM 8-K/A d822647d8ka.htm 8-K/A 43564 2 EX-99.1 d822647dex991.htm EX-99.1 583802 3 EX-99.2 d822647dex992.htm EX-99.2 250910 Complete submission text file
 SEC Filings5 days ago 8-K - Warner Chilcott Ltd (0001620602) (Filer)  SEC Filings2 weeks ago S-4/A - Warner Chilcott Ltd (0001620602) (Filer)  SEC Filings1 month ago EFFECT - Warner Chilcott Ltd (0001620602) (Filer)  SEC Filings1 month ago

Mylan Launches Generic Oral Contraceptive Loestrin 24 Fe

Mylan said it recently launched a generic version of Warner Chilcott's oral contraceptive Loestrin 24 Fe in the U.S., following final FDA approval. The launch comes as brandmaker Actavis, which purchased Warner Chilcott last year, continues to ...
 FDA News1 week ago Mylan launches generic version of oral contraceptive  Individual.com1 week ago Mylan ships Loestrin 24 Fe generic  Chain Drug Review2 weeks ago Mylan introduces generic Loestrin 24 Fe in US markets  PharmaBiz2 weeks ago

Northern Ireland link to 'Luxleaks' tax scheme

Pharmaceutical firm Warner Chilcott, which has strong links to Northern Ireland , has emerged as one of hundreds of companies to have availed of complex tax-saving arrangements in Luxembourg. Warner Chilcott , now part of US firm Actavis , entered ...
 4 Traders1 week ago
Pharma Letter

Actavis' third-quarter sales jump 83 percent, lifted by Forest, Warner Chilcott acquisitions

Actavis announced Wednesday that third-quarter sales surged 83 percent year-over-year to $3.7 billion, boosted by products gained from the acquisitions of Forest Laboratories and Warner Chilcott, and topping analyst estimates of $3.6 billion. The ...
 FirstWord Pharma2 weeks ago Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19  4 Traders1 week ago Actavis third-qtr sales rocket, but loss posted  Pharma Letter2 weeks ago

Actavis rides success of branded drugs and M&A to positive Q3

Actavis ($ACT) has been on an M&A kick, inking deals with Forest Laboratories ($FRX) and Warner Chilcott to get its hands on branded products. Now, the company can celebrate the fruits of that labor. Revenue for the quarter rang in at $3.68 ...
 FiercePharma2 weeks ago

Mylan (MYL) Launches Generic Formulation of Warner Chilcott's Loestrin 24 Fe

Visit at for the
 Wall Street Business Network2 weeks ago

Warner Chilcott Has Returned 69.5% Since SmarTrend Recommendation (WCRX)

Written on Tue, 11/04/2014 - 7:20pm By Nick Russo SmarTrend identified an Uptrend for Warner Chilcott ( NASDAQ:WCRX ) on January 17th, 2013 at $13.53. In approximately 22 months, Warner Chilcott has returned 69.54% as of today's recent price ...
 Comtex SmarTrend2 weeks ago Warner Chilcott Up 69.5% Since SmarTrend Uptrend Call (WCRX)  Comtex SmarTrend3 weeks ago
Motley Fool

George Soros Just Bought These 3 Stocks: Should You?

Superinvestors like Warren Buffett and George Soros are closely watched figures within the investment community for a very good reason: they have a knack for consistently beating the broader markets. Soros, for instance, has averaged for stretches ...
 Motley Fool1 hour ago
Irish Times

Botox maker Allergan in $66bn deal with Actavis

Allergan, the maker of Botox, has agreed to sell itself in a $66 billion (€53 billion) deal with fellow drugs group Actavis, with rival Valeant bowing out of its six-month long bitter pursuit. Actavis said yesterday it will pay $219 for each ...
 Irish Times5 days ago Allergan Deal Worth $66 Billion  The Guardian Express5 days ago CNBC Transcript: CNBC Exclusive: Actavis CEO Brent Saunders and Allergan Chairman & CEO David Pyott Speak with CNBC's "Squawk on the Street"  CNBC5 days ago Actavis to spend $66 billion on Allergan  Yahoo! India5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less